Skip to main content

Biomarin Pharmaceutical Inc 10-Q for FY2026 Q1

Biomarin Pharmaceutical Inc (BMRN)

10-Q 2026-05-05 For: 2026-03-31
View Original
Added on May 05, 2026

About this 10-Q

Biomarin Pharmaceutical Inc filed this 10-Q on May 5, 2026, covering the quarter ended March 31, 2026 (FY2026 Q1).

Headline figures

Quarter ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$766.21M
up 2.8% from $745.15M a year earlier
Net income
$105.53M
down 43.2% from net income of $185.69M a year earlier
Diluted EPS
$0.54
down 43.2% from $0.95 a year earlier